We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ISSUES GUIDANCE ON DRUG TRIALS DURING PREGNANCY
FDA ISSUES GUIDANCE ON DRUG TRIALS DURING PREGNANCY
November 5, 2004
The FDA has issued a draft guidance for designing and conducting pharmacokinetic (PK) studies in pregnant women that aims to stimulate R&D of appropriate treatments for such patients.